119 results
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
Asthma, Asthma-COPD ... Overlap and COPD ... ACO = asthma-COPD ... overlap; ICS = ... #Differences #Algorithm
Algorithm for Evaluation for ACS In Patients with Chest Pain In The Emergency Department

https://bit.ly/chestpainalgorithm

#ACS #ChestPain #algorithm
Algorithm for Evaluation ... for ACS In Patients ... chestpainalgorithm #ACS ... #ChestPain #algorithm
Acute coronary syndrome: Assessment of acute chest pain of suspected cardiac origin #Management #EM #Student #ACS
origin #Management #EM ... #Student #ACS #
Acute Coronary Syndrome (ACS) Algorithm

Satya Patel, MD @SatyaPatelMD

#Acute #Coronary #Syndrome #ACS #Algorithm #Chest #Pain #diagnosis #cardiology
Coronary Syndrome (ACS ... ) Algorithm Satya ... Coronary #Syndrome #ACS ... #Algorithm #Chest
Algorithmic Approach to Anemia - Differential Diagnosis Framework by MCV

Microcytic (MCV < 80) "TAILS":
 • Thalassemia
Algorithmic Approach ... Microcytic (MCV ... Thalassemia • ACD ... Non-hemolytic: ACD ... #Algorithm #Differential
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
-> Low dose ICS ... Med/High dose ICS ... product used in COPD ... the dose of the COPD ... version is blue but COPD
Guide to systemic mastocytosis

Criteria for diagnosis: at least 1 major and 1 minor or 3 minor
(2 15 MCs in aggregates ... • >25% of all MCs ... codon 816 • MCs ... mediator release • MCs ... #diagnosis #clinical
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
for Asthma and COPD ... Combination - ICS ... Combination - ICS ... Corticosteroid - ICS ... #lung #asthma #copd
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... long-acting β2-agonists; OCS ... StepUp #Treatment #Algorithm
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... Therapy (LAMA/LABA/ICS ... increase to 500 mcg ... low, adding an ICS ... won’t have any clinical